|
⚲
|
| UBS Para Fund LLC | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001300540 |
| Sale | 2004-08-01 ($243.2 M Sold) |
| Fund | |
| Phone | 8004862608 |
| Address | 1285 Avenue of The Americas New York, 10019 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Stephen Roussin | |
| Eric Brotman | |
| UBS Fund Advisor LLC | |
| Robert Aufenanger | |
| Craig Goos |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Ascendis Pharma A/S
✚
|
0.0 | |
|
Ascend NL SPV Jun 2025 a Series of CGF2021 LLC
✚
|
0.0 | |
|
Central Pointe Apartments LLC
✚
|
0.0 | |
|
Sweeney Kevin M
✚
|
0.0 | |
|
Ascend SMG Co-Invest 3, L.P.
✚
|
0.0 | |
|
Ascend Wellness Holdings, Inc.
✚
|
0.0 | |
|
Ascent Apollo Fund LLC
✚
|
0.0 | |
|
Ascent Care Partners, LLC
✚
|
0.0 | |
|
Ascent India Fund IV Private Ltd
✚
|
0.0 | |
|
Ascendco Health, Inc.
✚
|
0.0 |